blog
Silos Aren’t Going Away Any Time Soon
If we can’t eliminate silos, we need to embrace silos. We need to find ways
Lowering Risk in Pharma With Structured Content Authoring: What You Need to Know
To automate content development, pharmaceutical companies must move to structured content authoring.
Single-source publishing to multiple outputs for Pharma
In pharma, some digital marketing teams have embraced multi-channel publishing as a way to meet
What Pharma Labeling Content Can Teach Us About Content Reuse
Because labeling is global and requires localization, pharma companies gain even more benefit from content
Pharma Deserves Better
Legacy tools and processes no longer support the business objectives for pharma. The only way
Resistance Comes from a Place of Fear
To be successful, we need to get everyone on board with a change. Learn how
Structured Content for Pharma: Making the Case for XML
Learn how a structured content ecosystem results in better content for pharma companies and the
There’s No Such Thing as a Perfect Structure
There is no such thing as a perfect structure because it is going to change
The CDS is Dead! Long Live the CDS! Webinar
In this webinar, we present an improved solution for creating, storing, and managing critical CDS
Special Statements in Writing: 4 Rules for Notes, Cautions, and Warnings
I want to spend a few minutes talking about three types of special statements found
10 Ways an SCM Optimizes Your CDS
There are many reasons why a component structured content management (SCM) system is superior to
The CDS is Dead! Long Live the CDS!
The Company Core Data Sheet (CDS or CCDS) is one of the most important documents
A Walk Down Memory Lane
In honor of the 28th anniversary of Content Rules, I have gone into my personal
How to Create a Unified Content Experience
Raise your hand if you think content silos are ever going away. Yah. I didn’t
Getting Granular with eCTD v4.0
We talk a lot about the goal of enterprise content strategy for pharma: to help
Solving the XML Authoring Conundrum for Pharma
“We cannot change the authoring experience.” This, more than anything else, is the message we